Tumor Invasion Distance Based on MRI Is a Novel Prognostic Indicator for I-IIIB Cervical Cancer Patients Treated with Radiotherapy
Open Access
- 16 June 2025
- journal article
- research article
- Published by MDPI AG in Current Oncology
- Vol. 32 (6) , 355
Abstract
Aims:This study aimed to identify the prognostic value of tumor invasion distance (TID) based on MRI findings in cervical-cancer (CC) patients treated with radiotherapy (RT). Methods: A total of 218 CC patients diagnosed at Fujian Cancer Hospital from December 2018 to December 2019 were included in the study. Cox regression analyses were conducted to identify independent prognostic factors for overall survival (OS), including low 1/3 vaginal involvement, a longer TID, and RT without chemotherapy. These factors were subsequently used to construct a nomogram for individualized risk prediction. Kaplan–Meier survival analysis was employed to evaluate survival outcomes and establish a risk stratification system. The performance of the new stratification was assessed using the linear trend χ2 test, Akaike information criterion, and Harrell’s concordance index. Results: A longer TID was associated with worse 3-year OS (p < 0.001, HR: 3.42, 95% CI: 1.67–7.00). A longer TID, lower 1/3 vaginal involvement, and concurrent chemotherapy were independent prognostic survival factors for CC patients. Compared with the 2018 FIGO staging system, the new risk stratification system provided better monotonicity with a higher linear trend χ2 value (28.03 vs. 9.35), better discriminatory ability with smaller Akaike information criterion (312 vs. 331), and a greater Harrell C statistic (0.74 vs. 0.65) for predicting 3-year OS. Conclusions: This was the first study to demonstrate the prognostic value of TID in CC patients who received RT. The new risk stratification system based on TID could complement the 2018 FIGO staging system in identifying high-risk patients for more intense treatment and care. Further prospective research with larger samples is warranted to confirm the significance of TID for CC patients treated with RT.Keywords
Funding Information
- Major Scientific Research Program for Young and Middle-aged Health Professionals of Fujian Province, China (2022ZQNZD008, 2022YNG04, 2022Y2015)
- High-level Talents Training Project of Fujian Cancer Hospital (2022ZQNZD008, 2022YNG04, 2022Y2015)
- Clinical Research Center for Precision Treatment of Gynecological Malignancies of Fujian Province (2022ZQNZD008, 2022YNG04, 2022Y2015)
This publication has 34 references indexed in Scilit:
- Magnetic resonance imaging and ultrasound examination in preoperative pelvic staging of early‐stage cervical cancer: post‐hoc analysis of SENTIX studyUltrasound in Obstetrics & Gynecology, 2025
- ACR Appropriateness Criteria® Pretreatment Evaluation and Follow-Up of Invasive Cancer of the Cervix: 2023 UpdateJournal of the American College of Radiology, 2024
- A novel nomogram and risk stratification for early metastasis in cervical cancer after radical radiotherapyCancer Medicine, 2023
- Interobserver agreement of transvaginal ultrasound and magnetic resonance imaging in local staging of cervical cancerUltrasound in Obstetrics & Gynecology, 2021
- Positron emission tomography with computed tomography imaging (PET/CT) for the radiotherapy planning definition of the biological target volume: PART 2Critical Reviews in Oncology/Hematology, 2019
- Tumor growth patterns on magnetic resonance imaging and treatment outcomes in patients with locally advanced cervical cancer treated with definitive radiotherapyInternational Journal of Clinical Oncology, 2019
- MRI of cervical cancer with a surgical perspective: staging, prognostic implications and pitfallsAbdominal Radiology, 2019
- Cancer of the cervix uteriInternational Journal of Gynecology & Obstetrics, 2018
- Magnetic resonance imaging for detection of parametrial invasion in cervical cancer: An updated systematic review and meta-analysis of the literature between 2012 and 2016European Radiology, 2017
- Assessment of Parametrial Response by Growth Pattern in Patients With International Federation of Gynecology and Obstetrics Stage IIB and IIIB Cervical Cancer: Analysis of Patients From a Prospective, Multicenter Trial (EMBRACE)International Journal of Radiation Oncology - Biology - Physics (IJROBP), 2015